CXCL1 and fatty liver disease: While inhibition of gut fungi or PGE2 synthase significantly inhibited hepatic PGE2, EP2, EP4, and chemokine (C-X-C motif) ligand 1 (CXCL1), and reduced the development of alcohol-associated hepatic steatosis.